
Please try another search
Breaking News
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1074 | 1007 | 1051 | 1213 | 1581 | 2440 |
Fund Return | 7.42% | 0.71% | 5.06% | 6.64% | 9.6% | 9.33% |
Place in category | 30 | 25 | 24 | 37 | 43 | 4 |
% in Category | 19 | 18 | 17 | 17 | 25 | 3 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BlackRock S&P 500 Index K | 17.14B | 1.43 | 12.50 | 12.94 | ||
BlackRock International Index K | 10.92B | 8.12 | 6.92 | 5.46 | ||
BlackRock International Index Instl | 10.92B | 8.13 | 6.85 | 5.40 | ||
BlackRock International Index Inv A | 10.92B | 8.13 | 6.60 | 5.14 | ||
BlackRock Equity Dividend Instl | 9.87B | 4.32 | 7.01 | 10.03 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Health Care Adm | 34.63B | 4.15 | 4.94 | 7.02 | ||
Fidelity Select Health Care | 10.35B | 5.87 | 5.20 | 8.62 | ||
T. Rowe Price Health Sciences | 7.36B | 4.25 | 3.25 | 8.01 | ||
Vanguard Health Care Inv | 6.25B | 4.15 | 4.89 | 6.97 | ||
Fidelity Advisor Health Care C | 6.23B | 5.87 | 3.92 | 6.99 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.77 | 823.79 | -0.03% | |
Boston Scientific | US1011371077 | 7.77 | 97.38 | +1.95% | |
Intuitive Surgical | US46120E6023 | 5.26 | 511.28 | +3.56% | |
AbbVie | US00287Y1091 | 4.46 | 211.52 | -0.97% | |
UnitedHealth | US91324P1021 | 4.41 | 483.31 | -0.56% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review